Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
TruMe Labs is a private U.S. health diagnostics and bioanalytics company focused on consumer-facing longevity and genetic testing. The company markets at-home saliva-based tests that use DNA methylation analysis to estimate biological age and track changes over time, alongside genetic reports covering APOE status, brain and lipid risk, and folate metabolism. TruMe positions its offerings as personalized wellness and preventive health tools rather than therapeutic drug programs, with reports intended to guide lifestyle optimization. Its historical messaging also describes a broader bio-analytics platform and app strategy aimed at aggregating longitudinal health, genetics, and lifestyle data. Overall, TruMe appears to operate at the intersection of biotech, diagnostics, and digital health rather than traditional therapeutics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on TruMe Labs.